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Table S1. Percentage of CAs I, II, IX and XII inhibition on two concentrations of 
compounds 1-23 
 Percentage of inhibition 
 at 10-7(10-4) M 
Compound R- hCA I hCA II hCA IX hCA XII 
1 4-Me 20 (30) 34 (35) 29 (44) 33 (48) 
2 4-Et 21 (37) 35 (37) 29 (46) 41 (52) 
3 4-i-Pr 17 (36) 31 (45) 24 (47) 33 (47) 
4 4-n-Bu 25 (39) 35 (45) 33 (51) 42 (52) 
5 4-t-Bu 20 (39) 36 (45) 30 (52) 41 (51) 
6 2,4-di-Me 15 (32) 36 (38) 33 (50) 42 (49) 
7 3,4-di-Me 19 (30) 33 (37) 28 (50) 35 (46) 
8 2,4,5-tri-Me 20 (33) 33 (39) 30 (54) 35 (48) 
9 2,3,5,6-tetra-Me 28 (34) 34 (41) 29 (50) 36 (46) 
10 2,4,6-tri-Et 24 (33) 35 (45) 30 (49) 39 (47) 
11 2,4-di-i-Pr 22 (44) 35 (43) 27 (52) 33 (49) 
12 2,4,6-tri-i-Pr 17 (39) 34 (49) 26 (52) 37 (52) 
13 β-Tetralinyl 24 (33) 19 (25) 33 (49) 43 (51) 
14 β-Naphtyl 21 (36) 35 (38) 29 (48) 42 (54) 
15 4-Phenyl 19 (34) 34 (45) 32 (48) 42 (55) 
16 4-Pyrollidinyl 20 (36) 34 (48) 33 (46) 35 (52) 
17 4-F 20 (29) 32 (36) 29 (45) 36 (51) 
18 4-Cl 17 (30) 36 (38) 31 (45) 42 (50) 
19 3-Br 20 (32) 32 (35) 30 (54) 38 (49) 
20 4-OH 23 (30) 35 (41) 30 (45) 35 (51) 
21 2-OMe 21 (30) 28 (40) 27 (44) 35 (50) 
22 4-OMe 25 (30) 36 (40) 33 (51) 34 (47) 
23 4-OMe-2,5-diMe 22 (35) 35 (40) 33 (52) 42 (47) 
                                                 
* E-mail: claudiu.supuran@unifi.it (C.T. Supuran) 
** E-mail: bdrakuli@chem.bg.ac.rs (B.J. Drakulić) 
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Table S2. Calculated 3D-dependent whole-molecular properties of  
compounds 1-23 in its anionic form. 
Compound R- SA* PSA* ASA* Volume VLogP*
1 4-Me- 224.8130 64.0790 160.7340 177.4143 1.4671 
2 4-Et- 243.2491 64.0790 179.1701 192.8189 2.0007 
3 4-i-Pr- 264.0426 64.0790 199.9636 209.9865 2.0888 
4 4-n-Bu- 292.9753 65.6070 227.3683 230.5539 2.8327 
5 4-t-Bu- 282.4734 63.6160 218.8573 228.9744 2.6183 
6 2,4-di-Me- 246.8261 65.3018 181.5243 194.0475 1.9798 
7 3,4-di-Me- 242.2963 65.0251 177.2712 193.6693 1.9467 
8 2,4,5-tri-Me- 264.9485 64.5335 200.4150 212.3705 2.3428 
9 2,3,5,6-tetra-Me- 284.3445 65.9355 218.4090 228.3398 2.6140 
10 2,4,6-tri-Et- 327.5655 63.9959 263.5696 261.0485 3.4748 
11 2,4-di-i-Pr- 326.4613 64.9063 261.5551 261.1596 2.9713 
12 2,4,6-tri-i-Pr- 387.3279 64.1751 323.1528 311.0422 3.9021 
13 β-Tetralinyl- 268.1217 65.0251 203.0966 218.2483 2.3040 
14 β-Naphtyl- 251.6167 64.3173 187.2994 206.9182 1.9691 
15 4-Phenyl- 273.0847 64.9809 208.1038 228.0558 2.2108 
16 4-Pyrrolidinyl- 281.5775 67.1797 214.3978 229.2079 1.7434 
17 4-F- 205.8496 64.0790 141.7706 163.2093 1.2486 
18 4-Cl- 217.0917 64.0790 153.0126 174.1838 1.6192 
19 3-Br- 224.0955 64.6011 159.4944 179.5580 1.9400 
20 4-OH- 211.6867 87.4045 124.2822 168.2015 0.4326 
21 2-OMe- 236.4103 76.4652 159.9451 186.9544 0.9978 
22 4-OMe- 232.9842 75.3840 157.6001 185.6467 1.0959 
23 4-OMe-2,5-di-Me- 280.0472 75.7126 204.3346 222.4115 1.9971 
*SA- Surface area, PSA - Polar surface area, ASA - Apolar surface area, VlogP - Virtual logP 
 
Supplementary Material 
 
Figure S1. NOESY spectrum of 4-Me-derivative (1) in DMSO upon addition of the 1 molar 
equivalent of piperidine. 
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a) 
 
b) 
Figure S2. FT-IR spectra of a) 4-Et- (2), and b) 3,4-di-Me-derivative (7). In the IR spectrum of 
derivative 7 broadening of N-H bands in region of ~ 3100 cm-1 is observed, due to aggregation by 
intermolecular H-bonding. 
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a) b) 
Figure S3. Estimated pKa values of derivative 1. Tautomers with protonated pyrazole nitrogens 
were used for prediction. 
 
 
 
a) 
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b) 
Figure S4. Best-ranked solutions of compounds 15 (a) and 1(b) docked into CA I. 
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b) 
Figure S5. Best-ranked solutions of compounds 15 (a) and 1(b) docked into CA II. 
 
Supplementary Material 
  
a) b) 
 
c) d) 
e) f) 
Figure S6. Shape complementarity of active and inactive compounds toward CA IX. a) Surfaces 
of compound 9 (red transparent) and the cleft of CAIX (gray semi-transparent) are shown. b) 2D 
depiction of shape complementarity of compound 9. c)  2D depiction of shape complementarity 
of compound 5. d) 2D depiction of shape complementarity of compound 11. e) 2D depiction of 
shape complementarity of compound 15. f) 2D depiction of shape complementarity of compound 
13. 
 
 
 
 
 
 
 
Supplementary Material 
 
a) 
 
b) 
Supplementary Material 
 
c) 
Figure S7. Best-ranked solutions of compounds 4 (a), 2 (b), and 9 (c) docked into CA XII. 
 
 
Figure S8. Molecular interaction fields of HBA probe (O) around residue 67 of carbonic 
anhydrase ( hCA I  - His, hCA II - Asn, hCA IX - Gln,  hCA XII - Lys), depicted on isocontour 
level of –6.2 kcal/mol. Color of fields:  hCA I - red, hCA II - orange, hCA IX - yellow, hCA XII - 
blue.  
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Figure S9. Labeled residues within the box used for GRID molecular-interaction fields 
calculation, exemplified on the hCA XII (PDB entry 1JD0). Active site Zn2+ ion is depicted as an 
orange sphere.  
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Figure S10. 1H NMR spectrum of compound 4. 
 
 
Figure S11. 13C NMR spectrum of compound 4. 
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Figure S12. 1H NMR spectrum of compound 5. 
 
 
Figure S13. 13C NMR spectrum of compound 5. 
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Figure S14. 1H NMR spectrum of compound 8. 
 
 
Figure S15. 13C NMR spectrum of compound 8. 
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Figure S16. 1H NMR spectrum of compound 9. 
 
 
Figure S17. 13C NMR spectrum of compound 9. 
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Figure S18. 1H NMR spectrum of compound 10. 
 
 
Figure S19. 13C NMR spectrum of compound 10. 
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Figure S20. 1H NMR spectrum of compound 11. 
 
 
Figure S21. 13C NMR spectrum of compound 11. 
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Figure S22. 1H NMR spectrum of compound 12. 
 
 
Figure S23. 13C NMR spectrum of compound 12. 
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Figure S24. 1H NMR spectrum of compound 13. 
 
 
Figure S25. 13C NMR spectrum of compound 13. 
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Figure S26. 1H NMR spectrum of compound 16. 
 
 
Figure S27. 13C NMR spectrum of compound 16. 
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Figure S28. 1H NMR spectrum of compound 22. 
 
 
Figure S29. 13C NMR spectrum of compound 22. 
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Figure S30. 1H NMR spectrum of compound 23. 
 
 
    Figure S31. 13C NMR spectrum of compound 23. 
 
